| Anti‐gp210 and anti‐centromere antibodies are different risk factors for the progression of primary biliary cirrhosis M Nakamura, H Kondo, T Mori, A Komori, M Matsuyama, M Ito, Y Takii, ... Hepatology 45 (1), 118-127, 2007 | 465 | 2007 |
| New serological markers in inflammatory bowel disease are associated with complicated disease behaviour M Ferrante, L Henckaerts, M Joossens, M Pierik, S Joossens, N Dotan, ... Gut 56 (10), 1394-1403, 2007 | 384 | 2007 |
| Autoimmune acute liver failure: proposed clinical and histological criteria RT Stravitz, JH Lefkowitch, RJ Fontana, ME Gershwin, PSC Leung, ... Hepatology 53 (2), 517-526, 2011 | 343 | 2011 |
| AFP, AFP-L3, DCP, and GP73 as markers for monitoring treatment response and recurrence and as surrogate markers of clinicopathological variables of HCC K Yamamoto, H Imamura, Y Matsuyama, Y Kume, H Ikeda, GL Norman, ... Journal of gastroenterology 45, 1272-1282, 2010 | 274 | 2010 |
| IL-2 receptor alpha deficiency and features of primary biliary cirrhosis CA Aoki, CM Roifman, ZX Lian, CL Bowlus, GL Norman, Y Shoenfeld, ... Journal of autoimmunity 27 (1), 50-53, 2006 | 205 | 2006 |
| Reassessment of intrinsic factor and parietal cell autoantibodies in atrophic gastritis with respect to cobalamin deficiency E Lahner, GL Norman, C Severi, S Encabo, Z Shums, L Vannella, ... Official journal of the American College of Gastroenterology| ACG 104 (8 …, 2009 | 199 | 2009 |
| New serological markers for inflammatory bowel disease are associated with earlier age at onset, complicated disease behavior, risk for surgery, and NOD2/CARD15 genotype in a … M Papp, I Altorjay, N Dotan, K Palatka, I Foldi, J Tumpek, S Sipka, ... Official journal of the American College of Gastroenterology| ACG 103 (3 …, 2008 | 182 | 2008 |
| Utility of serological markers in inflammatory bowel diseases: gadget or magic? M Papp, GL Norman, I Altorjay, PL Lakatos World journal of gastroenterology: WJG 13 (14), 2028, 2007 | 171 | 2007 |
| PBC screen: an IgG/IgA dual isotype ELISA detecting multiple mitochondrial and nuclear autoantibodies specific for primary biliary cirrhosis H Liu, GL Norman, Z Shums, HJ Worman, EL Krawitt, N Bizzaro, ... Journal of autoimmunity 35 (4), 436-442, 2010 | 151 | 2010 |
| Antimitochondrial antibodies in acute liver failure: implications for primary biliary cirrhosis PSC Leung, L Rossaro, PA Davis, O Park, A Tanaka, K Kikuchi, ... Hepatology 46 (5), 1436-1442, 2007 | 149 | 2007 |
| Primary biliary cirrhosis (PBC), PBC autoantibodies, and hepatic parameter abnormalities in a large population of systemic sclerosis patients S Assassi, MJ Fritzler, FC Arnett, GL Norman, KR Shah, P Gourh, ... The Journal of rheumatology 36 (10), 2250-2256, 2009 | 147 | 2009 |
| Value of Isolated IgA Anti–β2‐Glycoprotein I Positivity in the Diagnosis of the Antiphospholipid Syndrome V Murthy, R Willis, Z Romay‐Penabad, P Ruiz‐Limón, ... Arthritis & Rheumatism 65 (12), 3186-3193, 2013 | 132 | 2013 |
| Autoantibodies to domain 1 of beta 2 glycoprotein 1: a promising candidate biomarker for risk management in antiphospholipid syndrome M Mahler, GL Norman, PL Meroni, M Khamashta Autoimmunity reviews 12 (2), 313-317, 2012 | 122 | 2012 |
| The spectrum of autoantibodies in IPEX syndrome is broad and includes anti-mitochondrial autoantibodies M Tsuda, TR Torgerson, C Selmi, E Gambineri, M Carneiro-Sampaio, ... Journal of autoimmunity 35 (3), 265-268, 2010 | 118 | 2010 |
| Clinical Characterization of Antiphospholipid Syndrome by Detection of IgG Antibodies Against β2‐Glycoprotein I Domain 1 and Domain 4/5: Ratio of Anti–Domain … L Andreoli, CB Chighizola, C Nalli, M Gerosa, MO Borghi, F Pregnolato, ... Arthritis & rheumatology 67 (8), 2196-2204, 2015 | 109 | 2015 |
| Prognostic implications of antibodies to Ro/SSA and soluble liver antigen in type 1 autoimmune hepatitis AJ Montano‐Loza, Z Shums, GL Norman, AJ Czaja Liver International 32 (1), 85-92, 2012 | 106 | 2012 |
| Antiphosphatidylserine/prothrombin antibodies (aPS/PT) as potential diagnostic markers and risk predictors of venous thrombosis and obstetric complications in antiphospholipid … H Shi, H Zheng, YF Yin, QY Hu, JL Teng, Y Sun, HL Liu, XB Cheng, JN Ye, ... Clinical Chemistry and Laboratory Medicine (CCLM) 56 (4), 614-624, 2018 | 104 | 2018 |
| Anti-β2-glycoprotein I IgG antibodies from 1-year-old healthy children born to mothers with systemic autoimmune diseases preferentially target domain 4/5: might it be the … L Andreoli, C Nalli, M Motta, GL Norman, Z Shums, S Encabo, WL Binder, ... Annals of the rheumatic diseases 70 (2), 380-383, 2011 | 101 | 2011 |
| Closing the serological gap in the antiphospholipid syndrome: the value of “non-criteria” antiphospholipid antibodies N Zohoury, ML Bertolaccini, JL Rodriguez-Garcia, Z Shums, ... The Journal of rheumatology 44 (11), 1597-1602, 2017 | 99 | 2017 |
| Seroreactivity to microbial components in Crohn's disease is associated with ileal involvement, noninflammatory disease behavior and NOD2/CARD15 genotype … M Papp, I Altorjay, GL Norman, Z Shums, K Palatka, Z Vitalis, I Foldi, ... Inflammatory bowel diseases 13 (8), 984-992, 2007 | 99 | 2007 |
Maria PappUniversity of DebrecenVerified email at med.unideb.hu
